6PBC
Structural basis for the activation of PLC-gamma isozymes by phosphorylation and cancer-associated mutations
6PBC の概要
エントリーDOI | 10.2210/pdb6pbc/pdb |
分子名称 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma,1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1, CALCIUM ION, SODIUM ION, ... (4 entities in total) |
機能のキーワード | 1-phosphatidylinositol 4, 5-bisphosphate phosphodiesterase gamma-1, hydrolase |
由来する生物種 | Rattus norvegicus (Rat) 詳細 |
タンパク質・核酸の鎖数 | 1 |
化学式量合計 | 136019.99 |
構造登録者 | |
主引用文献 | Hajicek, N.,Keith, N.C.,Siraliev-Perez, E.,Temple, B.R.S.,Huang, W.,Zhang, Q.,Harden, T.K.,Sondek, J. Structural basis for the activation of PLC-gamma isozymes by phosphorylation and cancer-associated mutations. Elife, 8:-, 2019 Cited by PubMed Abstract: Direct activation of the human phospholipase C-γ isozymes (PLC-γ1, -γ2) by tyrosine phosphorylation is fundamental to the control of diverse biological processes, including chemotaxis, platelet aggregation, and adaptive immunity. In turn, aberrant activation of PLC-γ1 and PLC-γ2 is implicated in inflammation, autoimmunity, and cancer. Although structures of isolated domains from PLC-γ isozymes are available, these structures are insufficient to define how release of basal autoinhibition is coupled to phosphorylation-dependent enzyme activation. Here, we describe the first high-resolution structure of a full-length PLC-γ isozyme and use it to underpin a detailed model of their membrane-dependent regulation. Notably, an interlinked set of regulatory domains integrates basal autoinhibition, tyrosine kinase engagement, and additional scaffolding functions with the phosphorylation-dependent, allosteric control of phospholipase activation. The model also explains why mutant forms of the PLC-γ isozymes found in several cancers have a wide spectrum of activities, and highlights how these activities are tuned during disease. PubMed: 31889510DOI: 10.7554/eLife.51700 主引用文献が同じPDBエントリー |
実験手法 | X-RAY DIFFRACTION (2.46 Å) |
構造検証レポート
検証レポート(詳細版)をダウンロード